Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey: 2010–2013

Diabetes mellitus (DM) and atherosclerotic cardiovascular disease (ASCVD) both increase the risk for a major adverse cardiac event, and are therefore considered priority conditions clinically. Although guidelines encourage clinicians to treat them similarly, many researchers do not consider DM an AS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Endocrinol Metab
Main Authors: Feldman, David I., Valero-Elizondo, Javier, Salami, Joseph A., Rana, Jamal S., Ogunmoroti, Oluseye, Okunrintemi, Victor, Osondu, Chukwuemeka U., Spatz, Erica S., Virani, Salim S., Blankstein, Ron, Blaha, Michael J., Veledar, Emir, Nasir, Khurram
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739895/
https://ncbi.nlm.nih.gov/pubmed/31646284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/XCE.0000000000000151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados